From financial results to new acquisitions, here are seven key updates from spine and orthopedic devicemakers since Feb. 5.

Zimmer Biomet shares at $105 reveal value at 13 times adjusted earnings, as the company continues to grow despite a GLP-1 ...

4. Zimmer Biomet has entered into a definitive agreement to purchase Paragon 28, a medical device company focused exclusively on foot-and-ankle orthopedics.

Total revenue of $6.3M Includes $3.3 Million of Product Revenue in Addition to a One-Time Upfront Payment of $3.0 Million in License Revenue from ...

BD announced it would split from its biosciences and diagnostics unit, while Zimmer Biomet updated investors on its $1.1 ...

NeuroOne Medical Technologies Corporation ( NASDAQ: NMTC) Q1 2025 Earnings Conference Call February 12, 2025 8:30 AM ET ...

The global joint replacement devices market, valued at US$22.50 billion in 2023, is forecasted to grow at a robust CAGR of 4.8%, reaching US$23.42 ...

In a report released today, Caitlin Cronin from Canaccord Genuity maintained a Hold rating on Zimmer Biomet Holdings (ZBH – Research Report), ...

The firm spun out its dental and spine businesses ... With an ROA of 1.15%, the company may face hurdles in achieving optimal financial returns. Debt Management: Zimmer Biomet Holdings's debt ...

The firm spun out its dental and spine businesses in 2022. A Deep Dive into Zimmer Biomet Holdings's Financials Market Capitalization Analysis: Positioned below industry benchmarks, the company's ...

Zimmer Biomet Holdings ... Valued at $21.8 billion by market cap, the company offers orthopedic, dental, and spinal reconstructive implants, as well as bone cement and related surgical products.